[ad_1]
In the country he made 11 thousand. 968 molecular antigen assays (PCR) and 7650 for suspected coronavirus.
The rate of new illnesses in the last 14 days is 100,000. the population reaches 528.6 cases. The proportion of positive diagnostic tests in the last seven days is 6.1 percent.
In Lithuania, since the start of the pandemic, COVID-19 has affected 237 thousand people. 950 people.
Statistically recovered and currently alive 215 thousand. 31 people, declared 170 thousand. 500 recovered. Statistically, there are currently 14 thousand sick people. 365 people, the declared number of patients reaches 58 thousand. 896.
The Department of Statistics considers that a person declared sick has a confirmed case and the end of the disease has not been confirmed by a doctor. A statistically ill person is one for whom illness has been confirmed in the last 28 days. After this period, the person is considered statistically healthy.
According to the department, the statistical rate of patients may be more accurate to assess the morbidity of the population, since among the declared patients there may be cases in which the person is no longer ill but the general practitioner has not confirmed the end of the illness. .
A total of 3,818 people died in Lithuania from COVID-19. 7,724 deaths are directly and indirectly related to this infectious disease.
The coronavirus raises its head again. Epidemiologists promise that the third wave will not be as terrible as the second, but the threats of a new pandemic are perfectly visible. In Lithuania, the virus affects almost 40 young people almost every day.
People ages 50 to 99 died of COVID-19 on the last day
Fourteen people died from COVID-19 last day, ranging in age from 50 to 99, according to data released by the Department of Statistics on Thursday.
Six of the dead were between 80 and 89 years old and three between 90 and 99 years old. Two of the deaths were in the 60-69 and 70-79 age groups, one of which was between 50 and 59 years old.
All of these people died in hospitals.
The Statistics Department notes that the number of deaths per day is preliminary and can be replaced with records delayed within a few days.
A total of 3,818 people died in Lithuania from COVID-19. 7,724 deaths are directly and indirectly related to this infectious disease.
Most of the deaths from COVID-19 (1,372 people) were in the age group 80-89 years. The five dead were between 20 and 29 years old.
Hospitals are currently treating 1,190 COVID-19 patients, 125 of whom are in resuscitation.
Lithuanian hospitals are currently treating 1,190 COVID-19 patients, 125 of them in resuscitation, Statistics Lithuania reported on Thursday.
In addition, 1001 patients are administered oxygen, 76 patients receive artificial lung ventilation.
155 people were hospitalized for COVID-19 per day.
The new variety received a name
According to Danielius Naumovas, director of the Santara Clinics Biobank, a senior medical biologist, all positive cases of coronavirus are currently undergoing repeated molecular testing (PCR) in Lithuania to determine if they have the aforementioned E848K mutation.
Once established, a portion of the samples are sent for sequencing studies.
“If it can be seen that this mutation is present in several positive cases that are interrelated, then not all the samples are taken for sequencing studies, but only a part, because statistically it does not make sense to study all of them. It is very likely that they are all cases of the same variety. Furthermore, the sequencing studies are quite long and expensive ”, explained the researcher.
According to Naumov, a variety that has not had a code name until now will be called B.1.620. The director of the Santara Clinics Biobank and his colleagues Gytis Dudu and Ingrida Olendraite suggested giving it a unique name.
“It is probably not playable in Lithuanian or Anykščiai, as the commentators want. In fact, this variety is not very innovative, as it has been found in France, Germany, Belgium, even the United States. Its first case was detected in France. in February of this year. But it cannot be said that it appeared there, it is probable that they brought it, “said the biologist.
According to him, the variety is most likely native to Africa. Also, it was quite rare, so scientists did not pay much attention to this variety.
“It happened sporadically, one case a month or half a year. If a case does not spread and does not have special properties, but perhaps the case was very well isolated ”, considered D. Naumov.
Johnson & Johnson to begin vaccination
The drugmaker will be distributed to vaccination centers on Wednesday after the drugmaker announces that it intends to begin distributing and using the Johsnon & Johnson coronavirus vaccine.
This shipment of vaccines will be aimed at elderly people, patients with chronic diseases treated in hospitals, as well as people going to work in Lithuanian diplomatic and consular institutions in foreign countries.
The Janssen vaccine, developed by Janssen Pharmaceutica NV, part of the Johsnon & Johnson pharmaceutical group, is the fourth approved coronavirus product in the European Union.
Only one dose is needed for these vaccines.
